Lipoprotein(a) or Lp(a) is a type of a cholesterol particle which exists in blood and raises the probability of heart attacks together with strokes. Lp(a) levels differ from regular cholesterol because their primary control comes from genetic factors and people don't respond well to diet or exercise. The majority of people with elevated Lp(a) levels remain unaware of their condition until they develop cardiovascular health issues.
Standard cholesterol medications do not provide effective results for lowering Lp(a) levels. By participating in clinical trials, you obtain access to experimental treatments which specifically target Lp(a) while you help advance research that create new methods for preventing heart disease risk.
Interested in learning more about participation in our clinical research studies? Determine your eligibility by responding to a brief set of inquiries. By completing the form below, you grant us permission to connect with you via phone, text, or email, offering further details through our research team.
If these health challenges disrupt your daily routine, you might be eligible for a clinical research opportunity. Feel free to reach out by filling out the form provided or giving us a call. Once you've submitted, one of our specialized team members at Biopharma will promptly get in touch with you.